— Know what they know.
Not Investment Advice
Also trades as: EPN.AX (ASX) · $vol 0M

HDRPF OTC

Epsilon Healthcare Limited
1W: +0.0% 1M: +0.0% 3M: +614.3% YTD: +614.3% 1Y: +614.3% 3Y: -95.7% 5Y: -96.7%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $3.9M mcap · 353M float · 0.0000% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.9M
52W Range0.0014-0.01
Volume8,000
Avg Volume16
Beta0.75
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOPeter Giannopoulos
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2018-02-26
5 Goodyear Street
Southport, QLD 4215
AU
About Epsilon Healthcare Limited

Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant. Established in 2016, the firm is headquartered in Sydney, Australia. Epsilon Healthcare Limited adopted its current identity in February 2021, having previously been known as THC Global Group Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms